{"id":1062311,"date":"2015-07-24T03:41:48","date_gmt":"2015-07-24T07:41:48","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/longevity-medicine\/hypogonadism-pathology-britannica-com.php"},"modified":"2024-08-17T20:19:37","modified_gmt":"2024-08-18T00:19:37","slug":"hypogonadism-pathology-britannica-com","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/hypogonadism\/hypogonadism-pathology-britannica-com.php","title":{"rendered":"hypogonadism &#124; pathology &#124; Britannica.com"},"content":{"rendered":"<p><p>    hypogonadism,in men,    decreased testicular    function that results in     testosterone deficiency and     infertility.  <\/p>\n<p>    Hypogonadism is caused by hypothalamic, pituitary, and    testicular diseases. Hypothalamic and pituitary diseases that    may cause decreased testicular function include tumours and    cysts of the     hypothalamus, nonsecreting and prolactin-secreting        pituitary tumours, trauma,     hemochromatosis (excess iron storage), infections,    and nonendocrine disorders, such as chronic illness and    malnutrition. The primary testicular disorders that result in    hypogonadism in postpubertal men include     Klinefelter syndrome and related chromosomal    disorders, although these disorders usually manifest at the    time of     puberty.  <\/p>\n<p>    Other causes of hypogonadism in men include testicular    inflammation (orchitis)    caused by     mumps; exposure to gonadal toxins, including    alcohol,     marijuana, and several     anticancer drugs (e.g., cyclophosphamide,    procarbazine, and platinum); and radiation with     X-rays. Many of the disorders that cause        delayed puberty are sufficiently mild that affected    men do not seek care until well into adult     life. This particularly applies to those disorders    that decrease spermatogenesis and therefore     fertility but spare Leydig cell function.  <\/p>\n<p>    The clinical manifestations of hypogonadism in adult men    include decreased     libido, erectile dysfunction (inability to have or    maintain an     erection or to ejaculate), slowing of facial and    pubic hair growth and thinning of hair in those regions, drying    and thinning of the skin, weakness and loss of muscle mass, hot    flashes, breast enlargement,     infertility, small     testes, and     osteoporosis (bone thinning). The evaluation of men    suspected to have hypogonadism should include measurements of    serum     testosterone,     luteinizing hormone,     follicle-stimulating hormone, and     prolactin, in addition to the analysis of        semen. Men with hypogonadism who have decreased or    normal serum     gonadotropin concentrations are said to have    hypogonadotropic hypogonadism and may need to be evaluated for    hypothalamic or pituitary     disease with     computerized axial tomography or     magnetic resonance imaging (MRI) of the head. Men    with hypogonadism who have increased serum gonadotropin    concentrations are said to have hypergonadotropic hypogonadism,    and their evaluation should be focused on the causes of    testicular disease, including chromosomal disorders.  <\/p>\n<p>    Men with hypogonadism caused by a hypothalamic disorder,    pituitary disorder, or testicular disorder are treated with    testosterone. Testosterone can be given by intramuscular    injection or by patches or gels applied to the skin.    Testosterone treatment reverses many of the symptoms and signs    of hypogonadism but will not increase     sperm count. Sperm count cannot be increased in men    with testicular disease, although it is sometimes possible to    increase sperm count in men with hypothalamic or pituitary    disease by prolonged administration of     gonadotropin-releasing hormone or gonadotropins. In    men with testicular disease, viable sperm can sometimes be    obtained by aspiration from the testes for     in vitro fertilization.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.britannica.com\/science\/hypogonadism\" title=\"hypogonadism | pathology | Britannica.com\" rel=\"noopener\">hypogonadism | pathology | Britannica.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> hypogonadism,in men, decreased testicular function that results in testosterone deficiency and infertility. Hypogonadism is caused by hypothalamic, pituitary, and testicular diseases. Hypothalamic and pituitary diseases that may cause decreased testicular function include tumours and cysts of the hypothalamus, nonsecreting and prolactin-secreting pituitary tumours, trauma, hemochromatosis (excess iron storage), infections, and nonendocrine disorders, such as chronic illness and malnutrition. The primary testicular disorders that result in hypogonadism in postpubertal men include Klinefelter syndrome and related chromosomal disorders, although these disorders usually manifest at the time of puberty. Other causes of hypogonadism in men include testicular inflammation (orchitis) caused by mumps; exposure to gonadal toxins, including alcohol, marijuana, and several anticancer drugs (e.g., cyclophosphamide, procarbazine, and platinum); and radiation with X-rays. Many of the disorders that cause delayed puberty are sufficiently mild that affected men do not seek care until well into adult life. This particularly applies to those disorders that decrease spermatogenesis and therefore fertility but spare Leydig cell function. The clinical manifestations of hypogonadism in adult men include decreased libido, erectile dysfunction (inability to have or maintain an erection or to ejaculate), slowing of facial and pubic hair growth and thinning of hair in those regions, drying and thinning of the skin, weakness and loss of muscle mass, hot flashes, breast enlargement, infertility, small testes, and osteoporosis (bone thinning). The evaluation of men suspected to have hypogonadism should include measurements of serum testosterone, luteinizing hormone, follicle-stimulating hormone, and prolactin, in addition to the analysis of semen. Men with hypogonadism who have decreased or normal serum gonadotropin concentrations are said to have hypogonadotropic hypogonadism and may need to be evaluated for hypothalamic or pituitary disease with computerized axial tomography or magnetic resonance imaging (MRI) of the head. Men with hypogonadism who have increased serum gonadotropin concentrations are said to have hypergonadotropic hypogonadism, and their evaluation should be focused on the causes of testicular disease, including chromosomal disorders. Men with hypogonadism caused by a hypothalamic disorder, pituitary disorder, or testicular disorder are treated with testosterone. Testosterone can be given by intramuscular injection or by patches or gels applied to the skin. Testosterone treatment reverses many of the symptoms and signs of hypogonadism but will not increase sperm count. Sperm count cannot be increased in men with testicular disease, although it is sometimes possible to increase sperm count in men with hypothalamic or pituitary disease by prolonged administration of gonadotropin-releasing hormone or gonadotropins. In men with testicular disease, viable sperm can sometimes be obtained by aspiration from the testes for in vitro fertilization.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/hypogonadism\/hypogonadism-pathology-britannica-com.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246874],"tags":[],"class_list":["post-1062311","post","type-post","status-publish","format-standard","hentry","category-hypogonadism"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1062311"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1062311"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1062311\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1062311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1062311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1062311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}